George Francis Grose

Founded in 2001, American Capital Partners LLC (ACP) is a broker/dealer located in Hauppauge, New York. The firm has affiliated offices in New York City, Baldwin, New York, East Meadow, New York, Fairfield, Connecticut, Farmingdale, New York, Huntington, New York, Medford, New York and Scottsdale, Arizona. ACP serves the needs of experienced investors and traders who are willing and able to incur higher degrees of risk. They generally recommend securities listed on the NYSE and NASDAQ but they may also recommend other investments such as mutual funds and short sale and/or options strategies. ACP provides independent research. They are generalists that are opportunistic and employ a long/short investment philosophy. On the long side, ACP utilizes bottom-up, fundamental research to identify undervalued and under-followed companies without regard for market-cap or sector. In general, the firm does not invest in biotechnology or biopharmaceuticals. When recommending a long position, ACP looks for companies with low p/e, low price/cash flow, low price/book value and strong balance sheets, which generate cash and are profitable or will generate profit in the near term. On the short side, they position portfolios in order to hedge against economic or market downturns. In this instance, ACP looks for companies with high p/e or cash flow multiples, deteriorating business model or franchise value, poor or weakening cash flow and earnings and/or a change that undermines the business model.

Founded in 2001, American Capital Partners LLC (ACP) is a broker/dealer located in Hauppauge, New York. The firm has affiliated offices in New York City, Baldwin, New York, East Meadow, New York, Fairfield, Connecticut, Farmingdale, New York, Huntington, New York, Medford, New York and Scottsdale, Arizona. ACP serves the needs of experienced investors and traders who are willing and able to incur higher degrees of risk. They generally recommend securities listed on the NYSE and NASDAQ but they may also recommend other investments such as mutual funds and short sale and/or options strategies. ACP provides independent research. They are generalists that are opportunistic and employ a long/short investment philosophy. On the long side, ACP utilizes bottom-up, fundamental research to identify undervalued and under-followed companies without regard for market-cap or sector. In general, the firm does not invest in biotechnology or biopharmaceuticals. When recommending a long position, ACP looks for companies with low p/e, low price/cash flow, low price/book value and strong balance sheets, which generate cash and are profitable or will generate profit in the near term. On the short side, they position portfolios in order to hedge against economic or market downturns. In this instance, ACP looks for companies with high p/e or cash flow multiples, deteriorating business model or franchise value, poor or weakening cash flow and earnings and/or a change that undermines the business model.